This editorial reviews the work of Mayer et al. on the use of rFVIIa in patients who suffer intracerebral hemorrhage and gives a new hope of therapy which can prevent rebleed and clinical deterioration, and acknowledges the encouraging outcome of this therapy. It suggests that adjustment for blood pressure and the possible effect of blood pressure on factor VIIa should be taken into consideration. The reviewers also emphasize the role of surgical intervention and adequate support on the outcome of intracerebral hemorrhage.
– Maadh Aldouri